Effect of Photobiomodulation as a Preventive Treatment for Diabetic Foot

Inclusion Criteria: * Individuals diagnosed with type 2 Diabetes Mellitus (according to American Diabetes Association 2021 criteria), * both sexes, * between 18 and 75 years, * Individuals classified, according to the International Working Group on the Diabetic Foot (IWGDF- 2019) scale, as moderate to high risk for developing diabetic foot, Exclusion Criteria: * Pregnant women * Individuals diagnosed with type 1 diabetics, * Individuals with neuropathy secondary to uncontrolled conditions (hypothyroidism, vitamin B12 deficiency, alcoholism), * Individuals diagnosed with active infectious condition at the time of inclusion, * Individuals diagnosed with active ulcer or infectious skin lesion on the legs/feet, * Individuals with historic of osteomyelitis, * Individuals with Parkinson's disease, * Individuals with contracture condition, * Individuals with severe lower limb ischemia (Fontaine III and IV - Rutherford 4 to 6), * Individuals with a suspicious skin lesion for neoplasms or cutaneous dysplasias on the legs/feet * Individuals diagnosed with oncologic disease or undergoing treatment within the last 3 (three) months, * Individuals presenting unstable angina, recent acute myocardial infarction, history of severe arrhythmia within the last six months, * Individuals diagnosed with decompensated Chronic Obstructive Pulmonary Disease (COPD), * Inability to understand the ICF, * Inability to attend appointments regularly.